医学
皱纹
面部修复
不利影响
填料(材料)
外科
前瞻性队列研究
患者满意度
聚己内酯
鼻唇沟
多中心研究
随机对照试验
牙科
内科学
材料科学
复合材料
聚合物
老年学
作者
Marion Moers‐Carpi,Marie‐Odile Christen,Henry Delmar,P. Brun,Isaac Bodokh,Philippe Kestemont
出处
期刊:Dermatologic Surgery
[Ovid Technologies (Wolters Kluwer)]
日期:2021-03-09
卷期号:47 (7): 960-965
被引量:5
标识
DOI:10.1097/dss.0000000000002978
摘要
Age-related changes affecting facial areas can be corrected using minimally invasive dermal fillers. The use of polycaprolactone-dermal filler (PCL-filler) in aesthetics is increasing.To evaluate the long-term safety and efficacy of the PCL-filler, in a European, multicenter, prospective study.Subjects (n = 90) with moderate/severe nasolabial folds (Wrinkle Severity Rating Scale [WSRS]: 3 to 4) were treated on Day 0 with a single injection of similar volume on each side; safety and efficacy assessments were performed over an 18-month period. In 1 of the 3 study centers, safety was evaluated at 30 months.At Month 12 (M12; primary endpoint), 84% of subjects showed a ≥1-point improvement on the WSRS (M6: 92%; M18: 64%). From the investigator/subject's evaluation, from Day 7 to M12, Global Aesthetic Improvement was reported for >90% of subjects, with the effect maintained for up to 18 months in >80% of patients. Subjects/investigators reported high satisfaction and skin quality improvement. Most of the immediate injection-site reactions disappeared after 2 to 4 days. No severe or unexpected adverse events were reported.This study demonstrated the long-term safety and efficacy of the PCL-filler, with safety confirmed for up to 30 months.
科研通智能强力驱动
Strongly Powered by AbleSci AI